MARKER THERAPEUTICS, INC.: cashflow_financing
| Value | {"amount": 16697160, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 1999-07-27 – 2013-03-31 |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8cf01959-932f-49d9-a3b8-af1e808c7c40
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001424884-13-000037Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/cashflow-financing/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8cf01959-932f-49d9-a3b8-af1e808c7c40
History
- supersedes {"amount": 16690511, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} (evidence 0001554757-13-000346)